The 10-Q filing for EGH Acquisition Corp. paints a picture of a company caught between a high-quality capital reserve and significant execution risk. On one hand, the trust account is performing exceptionally well, generating millions in interest and raising the redemption floor. On the other hand, the company is legally stalled, with a lawsuit from NEC Fund creating a bottleneck that prevents the necessary audits for the Hecate merger from moving forward.
Investors are essentially weighing the quality of the Hecate asset and the safety of the $10.35 redemption value against the risk of a total deal collapse. The shift of the expected closing to Q4 2026 provides a clearer timeline but also narrows the window for error. The ultimate outcome depends on whether the legal dispute is a mere procedurality or a fundamental flaw in Hecate's corporate authority, making the resolution of the Delaware Court of Chancery proceedings the primary catalyst for the stock.